Across TCGA pan-cancer cohorts, LINC01848 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01848’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC01848 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01848 is over-expressed in tumor.
LUAD, LIHC, and LUSC are the cancer types where LINC01848 tumor–normal differential expression is most reproducible.